Stay updated with breaking news from Eclipse Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Synthego, the genome engineering company, today announced it has raised $200 million of growth capital, including a Series E financing led by...
/PRNewswire/ -- Synthego, the genome engineering company, today announced it has raised $200 million of growth capital, including a Series E financing led by...
Researchers from the National Institutes of Health (NIH) recently outlined plans in Neuron of a project that aims to accelerate research on Alzheimerâs disease and related dementias (ADRD). The ambitious project â the Induced Pluripotent Stem Cell Neurodegenerative Disease Initiative (iNDI) â will model more than 100 mutations associated with ADRD in isogenic induced pluripotent stem cell (iPSC) lines. To learn about some of the main challenges associated with generating a large library of edited iPSCs and the role that Synthego, a genome engineering company, is playing in the...